An Overview of the Production Challenges in the Life Sciences Sector
A recent report from Catalyx sheds light on the persistent production bottlenecks that life sciences companies continue to encounter. The gaps between the push for digital technologies and the realities of manufacturing processes reveal a significant challenge in operational efficiency.
Key Findings of the Report
According to the
2025 Life Sciences Line Clearance Benchmark Report, nearly two-thirds (63%) of pharmaceutical and medical device manufacturers still rely on manual processes for critical production line changes, despite the growing evidence of their inefficiency.
Mario L. Rocci Jr., CEO of Catalyx, emphasizes, "The constant pressure to maintain quality, comply with regulations, and deliver strong performance is immense. This study underscores the opportunity that digital and AI-powered systems provide to transform line clearance from a bottleneck into a driver of operational excellence."
Cleaning Errors in Production Lines
A crucial quality assurance process is line cleaning, which ensures production equipment is properly cleaned and configured between different product runs to avoid cross-contamination. However, the report indicates that 70% of companies reported experiencing at least one cleaning error in the past year, with 30% acknowledging six or more. These figures have stagnated since Catalyx first published its line clearance study in 2023, suggesting little progress has been made in addressing these issues.
The Failure of Digital Pilot Projects
While almost half of respondents had tested new technologies for line cleaning, actual implementation remains limited. As of 2025, only 11% of companies reported significant digitalization of their primary system components. An additional 26% are using hybrid approaches that combine manual processes with basic digital tools. Nonetheless, traditional paper checklists and manual inspections still dominate the industry’s approach.
Operational Pressures Mount
The operational impact of manually executing line clearance processes is substantial. Participants in the study indicated that basic line changes take an average of 30 minutes to two hours, while complex adjustments can exceed four hours. Four out of five respondents cited human error, issues related to equipment setup, and overlooked items as primary causes of production delays.
The Urgency for Regulatory Evolution
Regulatory bodies and industry leaders are collaborating to create a suitable framework for the deployment of AI-driven technologies. As these efforts unfold, it is becoming clear that conventional practices regarding line clearance must evolve to meet future expectations concerning oversight, transparency, and data management.
Dave Taylor, Product Manager at Catalyx, explains, "Once this framework is established, digitalization will become a regulatory necessity that enhances quality. Companies embracing digital methods not only improve their efficiency but also prepare for a future where regulators demand increased transparency, data integrity, and traceable results."
Detailed Insights from the Study
Catalyx conducted its second industry-wide benchmark survey on line clearance in the summer of 2025, which builds on its initial study from 2023 and draws from a pool of over 20,000 professionals worldwide. This study provides the most comprehensive view of current practices and trends in line clearance within the global life sciences manufacturing sector.
For more in-depth analysis, the complete report can be accessed online at
Catalyx's website.
About Catalyx
Catalyx specializes in optimizing processes in the life sciences and other highly regulated industries. With over 30 years of experience, the company employs a global team of more than 550 engineers and technology specialists. Catalyx has completed over 3,000 life sciences projects, providing automation, image processing, and professional services aimed at enhancing operational efficiency, regulatory compliance, and overall performance. Visit
www.catalyx.ai for more information.